Roundtable Discussion: Translating Complex mRNA Characterization Assays into QC-Ready Strategies to Reduce Downtime between Teams

9:30 am - Wednesday 25th February 2026

  • How to adapt AD assays into validated QC workflows to ensure reproducibility across sites and manufacturing scales
  • How to overcome challenges of assay transfer, variability, and lack of reference standards to safeguard consistency and compliance
  • How to embed standardized characterization workflows to support smoother regulatory submissions, tech transfer and global comparability

Speakers:

Senior Director - Analytical Development & Quality Control
Arcturus Therapeutics
Director, Analytical Development
Tessera Therapeutics